COPD patients breathe easy with Aerosoon technology
COPD
Chronic Obstructive Pulmonary Disease (COPD) is one of the most serious lung diseases prevalent today affecting 65 million people worldwide.
From moderate chronic bronchitis to severe emphysema, COPD covers a range of debilitating lung conditions that limit airflow to the lungs.
The World Health Organization (WHO) recognizes that bronchodilator medications are crucial for symptomatic management of COPD and to effectively treat severe exacerbations of the disease.
Aerosoon’s ground breaking technology and high performance aerosol drug delivery devices provide patients with quick and effective respiratory care.
COPD patients breathe easy with Aerosoon technology:
More and effective medication delivery
Faster patient response
Quick response & easy to operate